Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00900
|
|||||
Drug Name |
Timolol
|
|||||
Synonyms |
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole; (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; (S)-timolol; Apo-Timol; Apo-Timol (TN); Apo-Timop; Apo-Timop (TN); Aquanil; Betim; Betimol; Betimol (TN); Blocadren; Blocadren (TN); Gen-Timolol (TN); Istalol; Istalol (TN); L-714,465; MK-950; Novo-Timol; Nu-Timolol; Nu-Timolol (TN); Optimol; PMS-Timolol (TN); Phoxal-timolol; Phoxal-timolol (TN); Proflax; S(-)-Timolol maleate; S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole; TIM; Temserin; Tenopt; Tim-AK; Tim-AK (TN); Timacar; Timolol (INN); Timolol (TN); Timolol GFS; Timolol Maleate, (1:1) Salt; Timolol [USAN]; Timololum; Timololum [INN-Latin]; Timopic; Timoptic (TN); Timoptic OcuDose; Timoptic OcuDose. (TN); Timoptic-XE; Timoptic-XE (TN); Timoptol
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
Therapeutic Class |
Antiarrhythmic Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C13H24N4O3S
|
|||||
Canonical SMILES |
CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
|
|||||
InChI |
InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1
|
|||||
InChIKey |
BLJRIMJGRPQVNF-JTQLQIEISA-N
|
|||||
CAS Number |
CAS 26839-75-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 316.42 | Topological Polar Surface Area | 108 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 8 | |||
XLogP |
1.8
|
|||||
PubChem CID | ||||||
ChEBI ID |
ChEBI:9599
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Timolol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Relationship between urinary sodium excretion and pioglitazone-induced edema. J Diabetes Investig. 2010 Oct 19;1(5):208-11. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.